QUADRANT CAPITAL GROUP LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1650717
CINCINNATI, OH
Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,552,422
+$353,626 QoQ
Shares Held
5,716
+17.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026QUADRANT CAPITAL GROUP LLC holds $22,161,348 across 129 Biotechnology names. VRTX ranks #2 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,677 | $2,840,997 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5,716 | $2,552,422 | |
| 3 | ARGX |
Argenx SE
|
2,778 | $2,028,634 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,605 | $1,363,639 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
49,144 | $1,361,288 | |
| 6 | EXEL |
Exelixis, Inc.
|
28,474 | $1,221,249 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
20,772 | $1,173,410 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
5,659 | $1,129,819 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,552,422 | 5,716 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,198,796 | 4,850 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,222,557 | 5,675 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,272,746 | 5,105 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,587,969 | 5,338 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,005,541 | 2,497 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,155,723 | 2,485 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,162,894 | 2,481 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $980,651 | 2,346 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $943,577 | 2,319 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $781,371 | 2,247 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $795,668 | 2,261 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $737,578 | 2,341 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $579,003 | 2,005 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $582,554 | 2,012 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $521,593 | 1,851 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $397,196 | 1,522 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $312,271 | 1,422 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $216,216 | 1,192 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $270,184 | 1,340 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $312,020 | 1,452 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $335,602 | 1,420 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $344,231 | 1,265 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $362,597 | 1,249 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $597,702 | 2,512 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||